Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Recent blog posts
Latest Hotspot
8 min read
Graves disease Indication Strategy Report 2026: TSHR, Trials and Deals
21 July 2026
Graves disease indication strategy report covering epidemiology, TSHR biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Latest Hotspot
8 min read
Hyperthyroidism Indication Strategy Report 2026: TSHR, Trials and Deals
21 July 2026
Hyperthyroidism indication strategy report covering epidemiology, TSHR biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Latest Hotspot
8 min read
Hypothalamic obesity Indication Strategy Report 2026: MC4R, Trials and Deals
21 July 2026
Hypothalamic obesity indication strategy report covering epidemiology, MC4R biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Latest Hotspot
8 min read
Prader-Willi syndrome Indication Strategy Report 2026: MC4R, Trials and Deals
21 July 2026
Prader-Willi syndrome indication strategy report covering epidemiology, MC4R biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Latest Hotspot
8 min read
Lipodystrophy Indication Strategy Report 2026: LMNA, Trials and Deals
21 July 2026
Lipodystrophy indication strategy report covering epidemiology, LMNA biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Latest Hotspot
8 min read
Maturity-onset diabetes of the young Indication Strategy Report 2026: glucokinase, Trials and Deals
21 July 2026
Maturity-onset diabetes of the young indication strategy report covering epidemiology, glucokinase biology, active trials, competition and deal signals using...
Read →
Latest Hotspot
8 min read
Monogenic diabetes Indication Strategy Report 2026: glucokinase, Trials and Whitespace
21 July 2026
Monogenic diabetes indication strategy report covering epidemiology, glucokinase biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Latest Hotspot
8 min read
Prediabetes Indication Strategy Report 2026: GLP-1R, Trials and Deals
21 July 2026
Prediabetes indication strategy report covering epidemiology, GLP-1R biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Latest Hotspot
8 min read
Pediatric obesity Indication Strategy Report 2026: MC4R, Trials and Deals
21 July 2026
Pediatric obesity indication strategy report covering epidemiology, MC4R biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Latest Hotspot
8 min read
Bronchiolitis obliterans syndrome Indication Strategy Report 2026: JAK1, Trials and Deals
21 July 2026
Bronchiolitis obliterans syndrome indication strategy report covering epidemiology, JAK1 biology, active trials, competition and deal signals using PatSnap MCP...
Read →
Latest Hotspot
8 min read
Progressive pulmonary fibrosis Indication Strategy Report 2026: TGF-β1, Trials and Deals
21 July 2026
Progressive pulmonary fibrosis indication strategy report covering epidemiology, TGF-β1 biology, active trials, competition and deal signals using PatSnap MCP...
Read →
Latest Hotspot
8 min read
Hypersensitivity pneumonitis Indication Strategy Report 2026: TNF, Trials and Deals
21 July 2026
Hypersensitivity pneumonitis indication strategy report covering epidemiology, TNF biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
<
1
<<
757
758
759
760
761
>>
1222
>